Veradigm Total Assets 2010-2022 | MDRX
Veradigm total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Veradigm Annual Total Assets (Millions of US $) |
|
|---|---|
| 2022 | $1,505 |
| 2021 | $2,311 |
| 2020 | $2,918 |
| 2019 | $3,206 |
| 2018 | $3,181 |
| 2017 | $4,230 |
| 2016 | $3,832 |
| 2015 | $2,682 |
| 2014 | $2,464 |
| 2013 | $2,620 |
| 2012 | $2,350 |
| 2011 | $2,504 |
| 2010 | $2,419 |
| 2010 | $1,095 |
| 2009 | $953 |
| Veradigm Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2022-12-31 | $1,505 |
| 2022-09-30 | $1,691 |
| 2022-06-30 | $1,714 |
| 2022-03-31 | $2,430 |
| 2021-12-31 | $2,311 |
| 2021-09-30 | $2,484 |
| 2021-06-30 | $2,540 |
| 2021-03-31 | $2,871 |
| 2020-12-31 | $2,918 |
| 2020-09-30 | $3,146 |
| 2020-06-30 | $3,189 |
| 2020-03-31 | $3,253 |
| 2019-12-31 | $3,206 |
| 2019-09-30 | $3,230 |
| 2019-06-30 | $3,235 |
| 2019-03-31 | $3,242 |
| 2018-12-31 | $3,181 |
| 2018-09-30 | $4,518 |
| 2018-06-30 | $4,354 |
| 2018-03-31 | $4,370 |
| 2017-12-31 | $4,230 |
| 2017-09-30 | $3,883 |
| 2017-06-30 | $3,784 |
| 2017-03-31 | $3,799 |
| 2016-12-31 | $3,832 |
| 2016-09-30 | $3,810 |
| 2016-06-30 | $3,710 |
| 2016-03-31 | $2,624 |
| 2015-12-31 | $2,682 |
| 2015-09-30 | $2,673 |
| 2015-06-30 | $2,704 |
| 2015-03-31 | $2,505 |
| 2014-12-31 | $2,464 |
| 2014-09-30 | $2,571 |
| 2014-06-30 | $2,593 |
| 2014-03-31 | $2,634 |
| 2013-12-31 | $2,620 |
| 2013-09-30 | $2,638 |
| 2013-06-30 | $2,676 |
| 2013-03-31 | $2,623 |
| 2012-12-31 | $2,350 |
| 2012-09-30 | $2,408 |
| 2012-06-30 | $2,481 |
| 2012-03-31 | $2,552 |
| 2011-12-31 | $2,504 |
| 2011-09-30 | $2,427 |
| 2011-06-30 | $2,446 |
| 2011-03-31 | $2,446 |
| 2010-12-31 | $2,419 |
| 2010-09-30 | $2,378 |
| 2010-06-30 | $0 |
| 2010-05-31 | $1,095 |
| 2010-03-31 | $0 |
| 2010-02-28 | $1,030 |
| 2009-12-31 | $976 |
| 2009-11-30 | $974 |
| 2009-09-30 | $0 |
| 2009-08-31 | $964 |
| 2009-05-31 | $953 |
| 2009-02-28 | $980 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.520B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.466B | 59.12 |
| Tempus AI (TEM) | United States | $12.696B | 0.00 |
| Doximity (DOCS) | United States | $11.914B | 53.01 |
| Hims & Hers Health (HIMS) | United States | $9.534B | 78.11 |
| IRhythm Technologies (IRTC) | United States | $5.093B | 0.00 |
| Hinge Health (HNGE) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.663B | 39.16 |
| Privia Health (PRVA) | United States | $2.603B | 192.82 |
| Heartflow (HTFL) | $2.489B | 0.00 | |
| Enovis (ENOV) | United States | $1.740B | 9.20 |
| Phreesia (PHR) | United States | $1.681B | 0.00 |
| 10x Genomics (TXG) | United States | $1.669B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 28.24 |
| Schrodinger (SDGR) | United States | $1.428B | 0.00 |
| Azenta (AZTA) | United States | $1.388B | 60.58 |
| Clover Health Investments (CLOV) | United States | $1.292B | 0.00 |
| Claritev (CTEV) | United States | $1.115B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.660B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.347B | 0.00 |
| Carlsmed (CARL) | $0.333B | 0.00 | |
| TruBridge (TBRG) | United States | $0.293B | 51.40 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.137B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.119B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.086B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |